Billionaire Jim Simons’ Latest Top Positions

RENAISSANCE TECHNOLOGIESRenaissance Technologies is an incredibly successful hedge fund. Founder Jim Simons is a billionaire many times over due to its successful performance and the fact that it has been able to keep AUM up and also charge above-market fees to investors. Much of the fund’s investing is quantitative and so might not be as informative on a delayed basis. However, in the second quarter Renaissance seems to have added to many of its stock positions, and looking at stocks that are near the top of its 13F portfolio and saw large increases from last quarter here are some investment themes that it looks like the fund is getting behind:

Apple and Microsoft. According to the 13F the two technology giants occupied the top two spots in the fund’s portfolio. Renaissance increased its holdings of Apple (NASDAQ:AAPL) by 31% and its holdings of Microsoft (NASDAQ:MSFT) by 89%, to positions of 970,000 and 15.8 million shares respectively. Apple has been on a hot streak the past few years as its smartphone and tablet products are now driving its business. Microsoft has finally awakened to these trends in the technology market and has announced a new self-produced tablet product to accompany the launch of its new versions of Windows and Office, but its stock price has not reacted too highly to the company’s initiatives. Both companies are priced at a trailing P/E of 15; Microsoft is expected to see a bump in earnings over the next year as many consumers and businesses buy the next versions of the company’s software, whether they need them or not, and Apple is expected by the sell-side to deliver strong enough growth to bring its forward P/E to 12. With Apple’s decision to start paying a dividend, both companies also pay moderate dividend yields. Both of these companies made our list of the ten most popular stocks among hedge funds in the first quarter.

Cigarettes. Double-digit percentage increases in share count of Philip Morris (NYSE:PM) and Lorillard (NYSE:LO) brought both companies into the top ten slots in the portfolio according to the 13F filing. Renaissance reported 3.9 million shares of Philip Morris, which has an international focus as opposed to the U.S. focus of sibling Altria Group, and 2 million shares of U.S.-centric Lorillard. Both companies reported fairly flat revenue and earnings growth in their most recent quarter compared to the same period the previous year. On a trailing basis, Philip Morris’s P/E is 18 and Lorillard’s is 16. As tobacco companies, they offer attractive dividend yields of 3.4% in the case of Philip Morris and 5% in the case of Lorillard.

Wal-Mart. A big increase brought Renaissance’s position to 3.7 million shares, up from about 150,000 at the end of the first quarter. The $240 billion market cap king of discount stores reported a 10% increase in earnings in its last quarter compared to a year ago, and has little market exposure with a beta of 0.4. Wal-Mart (NYSE:WMT) trades at a trailing P/E of 16 and a forward P/E of 14; we think this is reasonable for a market leader which is getting good profits growth despite its enormous size.

We’d say that Renaissance appears to think that consumer spending is a good factor to depend on across many products and price points. The fund has invested in tech companies producing flashy big-ticket computing items as well as tobacco companies, which are known for steady cash flow. The large increase in the Wal-Mart position also suggests a predicted move towards discount retail stores (at least for everyday items- perhaps Renaissance sees a world where consumers buy essentials at Wal-Mart and drop by the Apple Store to spend their savings?). Again, some of the fund’s activity may have come from short-term factors and so we can’t really be sure that Simons and his team are buying these stocks based on their suitability as long-term investments. As it happens, however, while the tobacco companies might be a bit overpriced relative to the other picks we can see an investor including any or all of these stocks in a portfolio on a value basis.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!